NIFTY
-45.05  -0.37%
 12080.85
S&P BSE SENSEX
-152.88  -0.37%
 41170.12
Biocon Ltd.
NSE : BIOCON BSE : 532523 ISIN code : INE376G01013
on 20-Feb-2020
NSE
8.95    2.92%
Rs. 315.05
 
Days Low
Rs. 305
Days High
Rs. 319.05

Open Rs. 305.8
 
52 week Low
Rs. 211.3
52 week High
Rs.320.48
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.315.00
8.95    2.92%
on 20-Feb-2020
BSE
8.95    2.92%
Rs. 315.00
 
Days Low
Rs. 305.8
Days High
Rs. 319

Open Rs. 305.95
 
52 week Low
Rs. 211.05
52 week High
Rs.320.98
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.315.05
8.95    2.92%
 
 
Last Price (Rs.)  315.00 Value  72696192.00
Net Change (Rs.)  8.95 Best Buy  0.00
Volume  230972 Best Sell  0.00
Prev.Close (Rs.)  306.05 Best Quantity  0
Open (Rs.)  305.80 Sell Quantity  0
High (Rs.)  319.05 52-Week High (Rs.)  320.48
Low (Rs.)  305.00 52-Week Low (Rs.)  211.30
Face Value (Rs.)  5 Market Cap.(Rs/ Mn)  378000.00
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital3000.00 3000.00 1000.00 
Share Capital3000.00 3000.00 1000.00 
Share Capital3000.00 3000.00 1000.00 
Share Capital3000.00 3000.00 1000.00 
Share Capital3000.00 3000.00 1000.00 
Currents Investments1134.00 4538.00 5247.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 404.90 971491 100.28 118.97 0.68
Divis Lab 2168.60 575695 280.36 43.20 0.74
Dr. Reddys Lab 3256.50 541110 884.09 42.32 0.61
Torrent Pharma 2235.80 378317 336.66 50.76 0.76
Ranbaxy Labs. 859.90 366028 1.53 0.00 0.00
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2019Sep 2019Jun 2019
Net Sales5013.005239.004808.00
Operating Profit1282.001502.00987.00
PBDT1831.001498.001802.00
Net Profit1207.001061.001119.00
More> 
 
Company News
2/7/2020 12:00:00 AM
Amalgamation Of Biocon Research Limited ("BRL") With Biocon Biologics...
1/27/2020 12:00:00 AM
Biocon informs about company updates
1/27/2020 12:00:00 AM
USFDA completes PAI, GMP inspection at Biocon’s Bengaluru facility
More>
 
Ratios
   Earnings Per Share (Rs)8.21 
   Book NAV/Share(Rs)117.59 
   PAT Margin (%)17.08 
   Asset Turnover(x)0.37 
   PER(x)37.20 
   Yield(%)0.16 
   EV/Core EBITDA(x)72.30 
   M Cap / Sales12.71 
   Net Sales Growth(%)19.24 
   PAT Growth(%)106.58 
   Total Debt/Equity(x)0.01 
   Current Ratio(x)2.46 
   Quick Ratio(x)1.72 
   Total Debt/Mcap(x)0.00 
More>